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Abstract
Inorganic nitrate was once considered an oxidation end-product of nitric oxide metabolism with 
little biological activity. However, recent studies have demonstrated that dietary nitrate can 
modulate mitochondrial function in man and is effective in reversing features of the metabolic 
syndrome in mice. Using a combined histological, metabolomics, and transcriptional and protein 
analysis approach we mechanistically define that nitrate not only increases the expression of 
thermogenic genes in brown-adipose tissue but also induces the expression of brown adipocyte-
specific genes and proteins in white adipose tissue, substantially increasing oxygen consumption 
and fatty acid Ś-oxidation in adipocytes. Nitrate induces these phenotypic changes through a 
mechanism distinct from known physiological small molecule activators of browning, the recently 
identified nitrate-nitrite-nitric oxide pathway. The nitrate-induced browning effect was enhanced 
in hypoxia, a serious co-morbidity affecting white adipose tissue in obese individuals, and 
corrected impaired brown adipocyte-specific gene expression in white adipose tissue in a murine 
model of obesity. Since resulting beige/brite cells exhibit anti-obesity and anti-diabetic effects, 
nitrate may be an effective means of inducing the browning response in adipose tissue to treat the 
metabolic syndrome.
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The diffuse and complex nature of the metabolic syndrome integrates peripheral insulin 
resistance and visceral obesity with cardiovascular disease; making the discovery of 
underlying molecular mechanisms that unite the aspects of the metabolic syndrome both 
challenging and essential. The perturbation of nitric oxide (NO) synthesis and signaling has 
emerged as a potential modulator of both cardiovascular morbidity and metabolic 
dysfunction (1; 2).
Until recently inorganic nitrate was considered a non-bioactive product of NO oxidation (3). 
However, a number of studies have identified nitrate treatment of humans and rodents as 
having effects similar to NO (4; 5). The discovery of anti-obesity effects of nitrate in 
rodents, including weight loss, a reduction of body fat, reversal of lipodystrophy and an 
improvement in glucose and insulin homeostasis, may highlight nitrate as having therapeutic 
potential for the treatment of the metabolic syndrome (6).
Dietary nitrate increases the circulating concentration of cGMP in humans (7) and low 
nitrate/nitrite diets decrease steady-state concentrations of cGMP in a number of tissues (8). 
Recently, cGMP has been shown to regulate energy balance in white adipocytes (9). The 
development of a brown adipocyte-like phenotype in white adipocytes, a process known as 
“ browning”, includes the induction of thermogenesis, the dissipation of chemical energy to 
produce heat (10; 11). Peroxisome proliferator activated receptor ś co-activator 1ř
(PGC-1ř) activates key components of the thermogenic program in white adipocytes, 
including fatty acid oxidation, mitochondrial biogenesis, and increased oxygen consumption 
(12). The thermogenic process occurs through the activity and increased expression of 
several brown-adipocyte specific genes including uncoupling protein 1 (UCP1), an inner 
mitochondrial membrane protein that uncouples the mitochondrial proton gradient (13). 
Cells expressing brown-adipocyte specific genes are interspersed within the white adipose 
tissue (WAT) of rodents and humans (so-called “ beige” or “ brite” cells) (14; 15)) and 
demonstrate anti-diabetic and anti-obesity effects in rodent models (16-19). The recent 
discovery of a physiological small molecule activator of browning in WAT highlights 
metabolites as both potential mediators of the thermogenic response and therapeutics for the 
metabolic syndrome (20).
In this study we investigate the effect of nitrate on WAT metabolism both in the classic 
experimental model of browning in vitro, the mouse primary adipocyte, and in vivo in mice 
and rats to establish whether this may, in part, explain the anti-obesity activity of nitrate. We 
demonstrate that nitrate increases the expression of brown-adipocyte specific genes and 
concordant proteins within white adipocytes to confer a brown-adipocyte like phenotype.
Research Design and Methods
Animal Experimentation
Male Wistar rats (6 weeks old) (269 ± 2 g; n = 24) (Charles River.) were weight matched 
and received either distilled water or water containing sodium nitrate (NaNO3) (0.35, 0.7, 
1.4 mM; n = 6/group) (Ultra-pure, Sigma-Aldrich) ad libitum for 18 days with food and 
water intake monitored. Animals were housed in conventional cages at room temperature 
with a 12-hour/12-hour light/dark photoperiod. In the hypoxia study, male Wistar rats (6 
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weeks old) were weight matched and separated into two groups (n = 10/group), housed in 
either normoxic or normobaric hypoxic environments (hypoxia chamber: 13% O2, with 20 
air changes per hour). The rats in each group received either distilled water containing NaCl 
(n = 5, 0.7mM NaCl) or water containing NaNO3 (0.7 mM; n = 5) for 14 days. All other 
details are as above.
Male p129 mice (6 weeks old) received either distilled water containing NaCl (0.7mM, 
Control, n = 7) or NaNO3 (0.7mM, n = 7) (Ultra-pure, Sigma-Aldrich) ad libitum for 15 
days with food and water intake monitored.
ob/ob mice (n = 10) and C57bl/6 wild type mice (n = 10) (9 weeks old, The Jackson 
Laboratory) received either distilled water containing NaCl (0.7mM, Control, n = 5) or 
NaNO3 (0.7mM, n = 5) (Ultra-pure, Sigma-Aldrich) ad libitum for 8 weeks with food and 
water intake monitored. Animals were housed in conventional cages at room temperature 
with a 12-hour/12-hour light/dark photoperiod.
All animals had micro-nutrient levels normalized by a standardized quality controlled (SQC) 
diet (RM1 (E); 55% crude carbohydrate, 3% crude fat, 15% crude protein; Special Diets 
Services, UK) one week prior to study commencement. The nitrate content of this diet is 2 
mg/Kg and the nitrite content was undetectable below a threshold of 1 mg/Kg.
All procedures were carried out in accordance with UK Home Office protocols by a 
personal license holder.
Blood and Tissue Collection
Rats and mice were euthanized with sodium pentobarbital (200 mg/ml, Vétoquinol UK 
Ltd.). Blood was obtained by cardiac puncture, collected in N-ethylmaleimide/EDTA (10 
and 2.5 mM, respectively) containing tubes and immediately centrifuged to obtain plasma. 
WAT and interscapular brown adipose tissue (iBAT) were removed and flash frozen in 
liquid nitrogen.
Histology
WAT was fixed for 24 hr in 10% formalin and washed for 1 hr in PBS before being set in 
wax. The tissue was then cut into 8 μm thick slices and stained with haematoxylin and eosin.
Plasma Nitrate Measurements
Plasma nitrate was measured as described previously (21).
Culture and Differentiation of Primary Adipocytes
Primary white adipose stromal vascular cells were fractionated from 6 – 10 week old 
C57BL6 male mice as previously described (22). Stromal vascular cells were then cultured 
and differentiated into adipocytes according to published methods (22; 23). During the 6 day 
differentiation, cells were cultured with either saline (control), 25 μM NaNO3, 50 μM 
NaNO3 or 500 μM NaNO3 (Ultra-pure, Sigma-Aldrich) or, during the investigation of the 
effects of sodium nitrite (NaNO2), with saline (control), 50 μM NaNO2 or 500 μM NaNO2 
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(Ultra-pure
,
 Sigma-Aldrich). The pharmacological inhibitor studies utilized 2-
Phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl 3-oxide (PTIO) (50 μM), NG-nitro-L-arginine 
methyl ester (L-NAME) (1 mM), 1H-[1,2, 4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) (1 
μM) (Sigma-Aldrich) and KT5823 (1 μM) (Santa Cruz Biotechnology). Cells were treated 
with PTIO, L-NAME, ODQ or KT5823 with and without 500 μM NaNO3. NaNO3 and 
inhibitors were added at day 1 of differentiation. In the hypoxia study, cells were isolated 
and differentiated as above. Hypoxic conditions were achieved using a New Brunswick 
Eppendorf Galaxy 14S incubator supplied with nitrogen and set to maintain a 2% O2 
environment.
siRNA Xanthine Oxidoreductase Knockdown
FlexiTube siRNA against XOR, AllStars negative control siRNA and HiPerFect 
Transfection Reagent were purchased from Qiagen. Transfection of primary adipocytes was 
carried out as per the manufacturer’ s instructions (75 ng siRNA, 3 μl transfection reagent per 
well,10 nM final siRNA concentration) on day 2 and 4 of differentiation.
Tissue and Primary Adipocyte Metabolite Extraction
Metabolites were extracted from WAT and primary adipocytes as previously described (24).
13C-palmitate Substrate Labeling Study
Palmitate was solubilized using a dialyzed albumin solution (24). At 6 days post-
differentiation medium was removed from primary adipocytes and replaced with serum free 
media containing insulin 850 nM, triiodothyronin 1 nM, and rosiglitazone 1 μM and 140 μM 
U-13C labeled palmitate (Cambridge Isotope Laboratories). After 2 days cells were collected 
and metabolites extracted as previously described. During the 8 days of the experiments 
duration, cells were cultured with either saline (control), 50 μM NaNO3 or 500 μM NaNO3.
Gene Expression Analysis
Total RNA extraction from WAT, BAT, and adipocytes, cDNA conversion and quantitative 
RT-PCR was performed according to published protocols (20). All data were normalized to 
18SrRNA (mouse WAT, BAT and adipocytes) or RLPL1 (rat WAT) and quantitative 
measures obtained using the Δ-Δ-CT method.
Protein Analysis
Analysis of UCP1 and PGC-1ř was performed using ELISA as per the manufacturer’ s 
instructions (UCP1 Kit SEF557Ra, PGC-1ř Kit SEH337Ra, Cloud-Clone Corp. Houston, 
TX, USA). Immunoblotting for CPT1 was carried out as previously described (25).
Citrate Synthase Assay
Citrate synthase was assayed according to Houle-Leroy et al.(26).
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White Adipocyte Respirometry
Oxygen consumption rates were measured in white adipocytes (250,000 cells) maintained in 
Krebs-Henseleit buffer at 37°C, using Clark-type oxygen electrodes (Strathkelvin 
Instruments, Strathkelvin, UK) as described previously (27).
Gas Chromatography-Mass Spectrometry Analysis
Dried aqueous and organic phase samples were derivatized using the method described 
previously (24). Gas Chromatography-Mass Spectrometry (GC-MS) and data analysis were 
performed according to published methods (24).
13C-labeled Substrate GC-MS Analysis
Analysis of organic and aqueous phases was carried out as described above and according to 
published methods (24).
Liquid Chromatography-Mass Spectrometry Analysis of Intact Lipids
Liquid Chromatography-Mass Spectrometry (LC-MS) was performed on WAT using a 
Waters Q-ToF Xevo mass spectrometer (Waters Corporation, Manchester, UK) operating 
with electrospray ionization in combination with an Acquity UPLC according to the method 
described by Roberts at al. (24). LC-MS spectra and chromatograms were analyzed using 
the MarkerLynx Application MassLynx (version 4.1; Waters Corporation) using published 
protocols (24).
LC-MS Analysis of cGMP
LC-MS analysis of cGMP was performed using a 4000 QTRAP triple quadrupole mass 
spectrometer (Applied Biosystems/Sciex), coupled to an Acquity UPLC (Waters 
Corporation, Manchester, UK) according to a previously described method (28). The 
multiple reaction monitoring parameters for cGMP were: Q1 = 346.13 m/z, Q3 = 152.1 m/z, 
collision energy = 23, declustering potential = 41, collision cell exit potential = 10.
Statistical Analyses
Error bars represent standard error of the mean. P-values were calculated by either one-way 
or two-way ANOVA as stated with a Dunnett’ s post-hoc test when multiple comparisons 
where made solely to control and a Tukey’ s post-hoc test when comparisons were made 
between all treatment groups.
Results
Nitrate Induces a Brown Adipocyte-like Phenotype in White Adipocytes In Vivo
Rodents treated with dietary nitrate are protected against diabetes and obesity (6). Activation 
of the browning response in WAT may represent a process underlying this altered systemic 
energy balance; therefore, we assessed the effect of dietary nitrate on the expression of 
brown adipocyte-specific genes in WAT in vivo. Wistar rats were treated with 0.35 mM, 0.7 
mM or 1.4 mM NaNO3 in drinking water for 18 days based on preliminary dose escalation 
studies. Plasma nitrate concentrations were found to increase in a dose-dependent fashion, 
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with the basal concentration in control rats at 11.1 ± 0.7 μM, increasing to 15.4 ± 2.0 μM, 
22.8 ± 4.0 μM, and 32.6 ± 5.0 μM in the rats treated with 0.35 mM, 0.7 mM and 1.4 mM 
NaNO3, respectively. Water and food intake was not significantly different between the 
groups (Table S1). Since it is the subcutaneous WAT that has the greatest predisposition to 
undergo browning and influence energy balance (23), we concentrated our analyses on the 
inguinal WAT depot. Nitrate dose-dependently increased brown adipocyte-specific gene 
expression in WAT. The expression of UCP-1 was increased, as was the molecular marker 
of brown-like adipocytes, cell death-inducing DFFA-like effector a (CIDEA), which has a 
role in the regulation of the thermogenic process (Fig. 1A). Expression of PGC-1ř, and the 
mitochondrial electron transport chain component cytochrome c (CYCS) were increased 
dose-dependently. Nitrate also increased expression of Ś-oxidation genes including carnitine 
palmitoyltransferase 1 (CPT1) and acyl-CoA dehydrogenase, very long chain (ACADvl) 
(Control vs. 0.35 mM NaNO3 P ≤ 0.01, Control vs. 0.7 mM NaNO3 P ≤ 0.0001, Control vs. 
1.4 mM NaNO3 P ≤ 0.001). Specific beige-selective genes, including T-box transcription 
factor (Tbx1), Transmembrane Protein 26 (Tmem26) and CD137, distinguish beige fat cells 
from both classical brown and white adipocytes (29). Nitrate moderately increased the 
expression of the beige-selective markers Tbx1, Tmem26 and CD 137 specifically 
characterizing these cells as beige adipocytes within the inguinal WAT depot (Fig. S1). 
Nitrate did not significantly change the expression of the canonical adipocyte-specific 
markers adiponectin (ADIPOQ) and fatty acid binding protein 4 (FABP4) in the WAT 
indicating that adipose tissue exposed to nitrate presents similar levels of adipogenesis (Fig. 
S2). Furthermore, analysis of brown-adipocyte specific gene expression in the visceral 
(epididymal) WAT of nitrate treated rats also revealed a moderate increase in the mRNA of 
several genes involved in the thermogenic and browning process (Fig. S3).
To determine whether changes in the expression of key brown adipocyte-specific genes 
were translated to the level of protein, the concentrations of UCP-1, PGC-1ř and CPT1 
protein in the subcutaneous WAT of nitrate treated rats were analyzed. Nitrate increased the 
expression of the brown-adipocyte specific proteins UCP-1 and PGC-1ř(Control vs. 0.35 
mM NaNO3 P ≤ 0.001, Control vs. 0.7 mM NaNO3 P ≤ 0.05, Control vs. 1.4 mM NaNO3 P 
= 0.01) (Fig 1.B). Nitrate also increased the concentration of the Ś-oxidation protein CPT1 
within WAT (Control vs. 0.35 mM NaNO3 P ≤ 0.05, Control vs. 0.7 mM NaNO3 P ≤ 0.05, 
Control vs. 1.4 mM NaNO3 P ≤ 0.05) (Fig. 1C). The observed induction of characteristic 
brown adipocyte genes and increase in the concentration of brown adipocyte-specific 
proteins suggests a browning of the subcutaneous WAT.
We next examined whether the changes in gene and protein expression induced by nitrate 
resulted in altered energy metabolism within the WAT. The activity of citrate synthase, a 
marker of mitochondrial density and TCA cycle flux, was significantly increased following 
nitrate treatment, suggesting increased mitochondrial biogenesis consistent with browning of 
WAT (Control vs. 0.35 mM NaNO3 P ≤ 0.05, Control vs. 0.7 mM NaNO3 P ≤ 0.05, Control 
vs. 1.4 mM P ≤ 0.01) (Fig. 1D). Since beige/brite cells utilize fatty acids as fuel for 
thermogenesis, we investigated whether nitrate affected lipid metabolism in the WAT of 
treated rats. GC-MS and LC-MS were utilized to measure total fatty acid and triacylglycerol 
(TAG) species in the WAT, respectively. Nitrate treatment increased the medium chain fatty 
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acid (MCFA) (laurate, myristate) / long chain fatty acid (LCFA) (arachidate, behenate) ratio, 
indicative of increased Ś-oxidation shortening fatty acid chain length (Control vs. 0.35 mM 
NaNO3 P ≤ 0.05, Control vs. 0.7 mM NaNO3 P ≤ 0.05, Control vs. 1.4 mM NaNO3 P ≤ 
0.01) (Fig. 1E and Fig. S4). LC-MS analysis demonstrated that nitrate also decreased the 
total TAG content within WAT (0.95-fold, 0.35 mM NaNO3; 0.94-fold, 0.7 mM NaNO3; 
0.98-fold, 1.4 mM NaNO3; Control vs. 0.35 mM P ≤ 0.01, Control vs. 0.7 mM P ≤ 0.01) 
(Fig. 1F). Therefore, metabolic changes induced in WAT in vivo by nitrate treatment were 
characteristic of a brown adipocyte-like phenotype.
Histological analyses of the inguinal WAT of nitrate treated rats at fifty-times magnification 
revealed the presence of fascicles of multilocular brown adipocyte-like cells (Fig 1G). Under 
greater magnification the smaller multilocular brown adipocyte-like cells can be observed 
confirming morphological changes in the WAT. Together these data indicate that nitrate 
induces the browning of WAT.
To ensure nitrate-induced expression of brown adipocyte-specific genes in rat WAT is not 
species-specific, mice were treated with 0.7 mM NaNO3 in drinking water. As in rat, brown 
adipocyte-specific gene expression was increased in inguinal WAT by nitrate treatment (Fig. 
S5A). The expression of thermogenic genes in classical iBAT from nitrate treated mice was 
also increased (Fig. S5B).
Nitrate Induces a Brown Adipocyte-like Phenotype in White Adipocytes In Vitro
Nitrate may function directly to increase the expression of brown adipocyte-specific genes 
in WAT or indirectly through metabolic bioactivation in cells distinct from those in the 
target tissue. Therefore stromal vascular fraction-derived primary adipocytes isolated from 
inguinal WAT of mice were treated with nitrate. NaNO3 concentrations of 25 μM, 50 μM 
and 500 μM were chosen. The latter two concentrations correspond to plasma levels in mice 
exhibiting improved metabolic phenotypes when chronically treated and acutely dosed with 
0.1 mmol/kg of NaNO3, respectively (6). Nitrate treatment significantly increased the 
expression of brown-adipocyte specific genes UCP-1, CIDEA and PGC-1ř. Also increased 
in expression were CYCS, CPT1 and ACADvl (Control vs. 25 μM NaNO3 P ≤ 0.01, Control 
vs. 50 μM NaNO3 P ≤ 0.0001, Control vs. 500 μM NaNO3 P ≤ 0.0001) (Fig. 2A). By 
contrast, nitrate did not significantly affect the expression of a panel of classical mature 
adipocyte-specific genes including ADIPOQ, FABP4, and adipsin, suggesting that nitrate 
dose not directly affect adipogenesis per se (Fig. S6) (29). These data indicate nitrate 
mediated induction of brown-adipocyte specific gene expression occurs directly at the 
WAT.
We next investigated whether the transcriptional changes induced by nitrate conferred 
functional effects on energy expenditure in primary adipocytes. The O2 consumption rates of 
adipocytes treated with nitrate (50 μM and 500 μM) were measured (Fig. 2B). The basal O2 
consumption rate was dose-dependently increased in adipocytes treated with nitrate (Control 
3.1 nmoles O2/min/106 cells, 50 μM NaNO3 4.5 nmoles O2/min/106 cells, 500 μM NaNO3 
5.1 nmoles O2/min/106 cells, P ≤ 0.05). Maximal respiratory rates were probed using excess 
succinate (20 mM) (27), and were found to increase in adipocytes treated with nitrate 
(Control 4.2 nmoles O2/min/106 cells, 50 μM NaNO3 6.6 nmoles O2/min/106 cells, 500 μM 
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NaNO3 7.7 nmoles O2/min/106 cells, P ≤ 0.05). These findings indicate that nitrate increases 
the respiration of adipocytes consistent with the browning response (Control vs. 50 μM 
NaNO3 P ≤ 0.01, Control vs. 500 μM NaNO3 P ≤ 0.001).
GC-MS analysis of the fatty acid metabolism of adipocytes treated with nitrate also 
highlighted the increase in the MCFA/LCFA ratio, mirroring the effects observed in WAT 
in vivo (Control vs. 50 μM NaNO3 P ≤ 0.05, Control vs. 500 μM NaNO3 P = 0.08) (Fig. 2C).
Nitrate Increases Fatty Acid Uptake and ͤ-oxidation in White Adipocytes In Vitro
To confirm the increased Ś-oxidation observed in nitrate treated adipocytes, the stable 
isotope substrate U-13C-palmitate was used to monitor flux through the fatty acid oxidation 
pathway. Primary adipocytes were incubated in serum-free media containing U-13C-
palmitate and treated with nitrate. GC-MS analysis was used to determine the relative 
enrichment of metabolites. Nitrate significantly increased the 13C enrichment of palmitate 
(C16:0) in adipocytes, indicating increased fatty acid uptake (P ≤ 0.01) (Fig. 3A). 
Enrichment of shorter chain fatty acids, myristate (C14:0) and laurate (C12:0) was also 
increased in nitrate treated adipocytes (C14:0 P ≤ 0.05, C12:0 P ≤ 0.05) (Fig. 3B and 3C), 
consistent with augmented chain shortening through Ś-oxidation.
The labeled fatty acids are catabolized releasing labeled acetyl-CoA which enters the TCA 
cycle. Nitrate treatment increased the labeling of TCA cycle intermediates, citrate (Control 
vs. 50 μM NaNO3 P ≤ 0.0001, Control vs. 500 μM NaNO3 P ≤ 0.001) (Fig. 3D), succinate 
(Control vs. 500 μM NaNO3 P ≤ 0.05) (Fig. 3E) and malate (Control vs. 500 μM NaNO3 P ≤ 
0.05) (Fig. 3F). Therefore, nitrate confers a functional effect on white adipocytes, increasing 
flux through fatty acid Ś-oxidation. Taken together, these data demonstrate that nitrate 
induces the expression of thermogenic genes and the development of a brown-fat like 
phenotype in white adipocytes and WAT.
Nitrate Functions through the Nitrate-Nitrite-NO Pathway to Induce Browning of 
Adipocytes
In addition to the classical L-arginine-nitric oxide synthase (NOS)-NO pathway, NO can 
also be generated in vivo from nitrate through serial reduction to nitrite and then to NO via 
the nitrate-nitrite-NO pathway (30). Therefore, we hypothesized that nitrate might be 
functioning via NO to produce the browning response in WAT. Primary adipocytes were 
differentiated in the presence of nitrate and the NO scavenger PTIO (Fig. 4A) (Control vs. 
500 μM NaNO3 P ≤ 0.0001, 500 μM NaNO3 vs. 500 μM NaNO3 + 50 μM PTIO P ≤ 
0.0001). Sequestration of NO by PTIO negated the nitrate-induced expression of brown 
adipocyte-specific genes, indicating that nitrate indeed functions via NO to induce 
browning.
To exclude the induction of NO production through the L-arginine-NOS-NO pathway as a 
mechanism of nitrate stimulated browning, control experiments were conducted using the 
non-isoform selective NOS inhibitor L-NAME. Inhibition of NOS did not affect nitrate-
stimulated brown adipocyte-specific gene expression in adipocytes (Fig. 4B) (Control vs. 
500 μM NaNO3 P ≤ 0.001, Control vs. 500 μM NaNO3 + 1mM L-NAME P ≤ 0.0001, 500 
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μM NaNO3 vs. 500 μM NaNO3 + 1mM L-NAME not significant). Therefore, nitrate 
stimulated browning functions through NO but independently of NOS.
An enzymatic mechanism for the reduction of nitrate to NO in mammals, catalyzed by 
XOR, was recently reported (4). XOR is expressed in WAT and has a role in adipocyte 
homeostasis (31). Nitrate dose-dependently increased the expression of XOR in primary 
adipocytes (Fig. 4C). Using PTIO, the nitrate stimulated increase in XOR expression was 
demonstrated to be mediated through NO (Fig. 4D). The expression of XOR in primary 
adipocytes was knocked down by approximately 80% using siRNA (Fig 4E). Knockdown of 
XOR abrogated the nitrate-induced expression of brown adipocyte-specific genes in white 
adipocytes (Fig 4F). Consistent with these results, nitrite promoted brown adipocyte-specific 
gene expression in adipocytes via an NO-dependent mechanism (Fig. S7A, B). By 
examining fold-increases of brown adipocyte-specific genes, nitrite at equivalent 
concentrations to nitrate appeared more potent in inducing the browning response, consistent 
with the inefficient overall rate of reduction of nitrate to nitrite and eventually NO (4). These 
results indicate that nitrate mediated browning of adipocytes requires XOR and the 
reduction of nitrate to NO.
Nitrate Increases Browning of Adipocytes Through a cGMP and Protein Kinase G Mediated 
Mechanism
We next characterized the downstream signaling/effector pathways mediating nitrate-
induced browning of WAT. NO activates cGMP signaling through stimulation of soluble 
guanylyl cyclase (3). cGMP mediates browning of WAT (9) suggesting cGMP signaling as 
a potential mechanism underlying nitrate-induced browning. Therefore, we measured the 
concentration of cGMP in nitrate treated adipocytes using LC-MS (Fig. 5A). Nitrate 
increased the concentration of cGMP in adipocytes, from 2.7 pmoles/106 cells in the control 
to 5.2 pmoles/106 cells and 4.9 pmoles/106 cells in the 50 μM NaNO3 and 500 μM NaNO3 
treated cells, respectively (P = 0.04, Control vs. 50 μM NaNO3 P ≤ 0.05, Control vs. 500 μM 
NaNO3 P ≤ 0.05) (Fig. 5B). Similarly, analysis of WAT from rats demonstrates an increase 
in cGMP concentrations in vivo, following nitrate treatment (P < 0.05, Control vs. 0.35mM 
NaNO3 P ≤ 0.01, Control vs. 0.7mM NaNO3 P ≤ 0.05, Control vs. 1.4mM NaNO3 P = 0.07) 
(Fig. 5C).
The pharmacological inhibitor of guanylyl cyclase, ODQ, was used to confirm a cGMP-
dependent mechanism for nitrate-induced browning. Inhibition of guanylyl cyclase 
abolished the nitrate-induced expression of brown adipocyte-specific genes in white 
adipocytes (Control vs. 500 μM NaNO3 P ≤ 0.0001, 500 μM NaNO3 vs. 500 μM NaNO3 + 
1 μM ODQ P ≤ 0.001) (Fig. 5D).
The cGMP-dependent protein kinase G (PKG) is expressed in the WAT of rodents and is a 
key regulator of adipocyte function (9; 32). Using a pharmacological inhibitor of PKG 
(KT5823) we investigated the role of this protein kinase in the nitrate-induced browning 
response. Inhibition of PKG abrogated the nitrate-induced expression of brown-adipocyte 
specific genes in the adipocytes (Control vs. 500 μM NaNO3 P ≤ 0.0001, 500 μM NaNO3 
vs. 500 μM NaNO3 + 1 μM KT5823 P ≤ 0.0001) (Fig. 5E). Therefore, the mechanism 
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underlying nitrate-induced browning of WAT functions through the cGMP/PKG signaling 
axis.
Nitrate Induced Browning of WAT is Enhanced In Hypoxia
Unlike the L-arginine-NOS-NO pathway, which is dependent on oxygen, production of NO 
through the nitrate-nitrite-NO pathway is augmented as oxygen concentrations decrease (33) 
and may regulate tissue adaptations to hypoxia (34; 35). Since the nitrate-induced browning 
of WAT is mediated through the nitrate-nitrite NO pathway, we examined the capacity of 
nitrate to increase brown adipocyte-specific gene expression in adipocytes during hypoxia.
Primary adipocytes were treated with NaNO3 (50 μM) in low oxygen conditions (2% O2). 
These oxygen concentrations correspond to levels observed in obese WAT (36). In parallel, 
adipocytes from the same stromal vascular isolation were treated with NaNO3 (50 μM) 
under normoxic conditions. Since nitrate-induced browning requires the reduction of nitrate 
to NO, and XOR functions to reduce nitrate to NO (4), we assessed the expression of XOR 
in the adipocytes in response to changes in oxygen availability. XOR expression was found 
to increase in adipocytes exposed to hypoxia, an effect enhanced by simultaneous nitrate 
treatment (Fig. 6A) (Normoxia Control vs. Hypoxia Control P ≤ 0.01, Hypoxia Control vs. 
Hypoxia 50 μM NaNO3 P ≤ 0.05, Normoxia 50 μM NaNO3 vs. Hypoxia 50 μM NaNO3 P ≤ 
0.001). Nitrate also increased the expression of brown adipocyte-specific genes in both the 
normoxia and hypoxia conditioned cells (Normoxia Control vs. Normoxia 50 μM NaNO3 P 
≤ 0.0001, Hypoxia Control vs. Hypoxia 50 μM NaNO3 P ≤ 0.0001) (Fig. S8A). Hypoxia per 
se significantly decreased the expression of the brown-adipocyte specific genes compared to 
normoxia (Normoxia Control vs. Hypoxia Control P ≤ 0.01). However, nitrate increased the 
expression of the brown-adipocyte specific genes and fully restored the expression of UCP1, 
CIDEA and CPT1 under hypoxia to levels greater than that of normoxic controls. The 
decrease in expression of the genes due to hypoxia alone was corrected for by normalizing 
the hypoxia conditioned cells to hypoxia control to facilitate comparison of the fold-changes 
in expression of the browning genes following nitrate treatment (Fig. 6B). The fold-change 
increase of brown adipocyte-specific gene expression in hypoxic adipocytes treated with 
nitrate compared to hypoxic control was significantly greater than that observed in normoxic 
cells (Normoxia 50 μM NaNO3 vs. Hypoxia 50 μM NaNO3 P ≤ 0.0001).
To investigate the enhanced browning effect of nitrate in WAT under hypoxic conditions in 
vivo, rats were housed in a hypoxia chamber and either received 0.7mM NaCl or 0.7 mM 
NaNO3 in their drinking water for 14 days. A parallel group of rats were identically treated 
but housed in a normoxic environment. Water and food intake was not significantly different 
between the groups (Table S2). As in vitro, XOR expression was increased in WAT of rats 
exposed to hypoxia, and further enhanced by nitrate treatment (Fig. 6C) (Normoxia Control 
vs. Hypoxia Control P ≤ 0.01, Normoxia 50 μM NaNO3 vs. Hypoxia 50 μM NaNO3 P ≤ 
0.01). As expected, nitrate increased expression of brown adipose-specific genes in WAT 
during normoxia (Normoxia Control vs. Normoxia 0.7 mM NaNO3, P ≤ 0.01) (Fig. 6D). 
Brown adipocyte-specific gene expression was also increased in the WAT of rats treated 
with nitrate under hypoxic conditions (Hypoxia Control vs. Hypoxia 0.7 mM NaNO3, P < 
0.0001). Interestingly, brown adipocyte-specific gene expression within WAT was 
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significantly increased in the rats treated with nitrate during hypoxia when compared to 
those treated with nitrate and housed in a normoxic environment (Normoxia 0.7 mM NaNO3 
vs. Hypoxia 0.7mM NaNO3, P < 0.0001). The expression of ADIPOQ was not significantly 
affected by either nitrate or hypoxia (Fig. S8B). Overall, these data indicate that the nitrate-
induced expression of brown adipocyte-specific genes in WAT is augmented in hypoxia.
The WAT of obese humans and rodents is in a hypoxic state that perturbs metabolism, 
increasing glycolysis and de novo lipogenesis and decreasing fatty acid breakdown, further 
contributing to the pathology of obesity (36-39). Therefore, we investigated the effect of 
dietary nitrate on the expression of brown adipocyte-specific genes in WAT in a rodent 
model of obesity, the ob/ob mouse. Wild-type C57bl/6 and ob/ob mice received either 0.7 
mM NaCl or 0.7 mM NaNO3 in their drinking water for 8 weeks. Plasma nitrate 
concentrations were elevated from 59.8 μM ± 4 and 53.8 μM ± 11 in the chloride treated 
C57bl/6 and ob/ob mice respectively to 373.1 ± 73 and 323.9 ± 58 in their nitrate treated 
counterparts. The expression of several brown adipocyte-specific genes in the WAT of 
ob/ob mice was significantly reduced when compared to wild-type mice. Nitrate increased 
the expression of the brown adipocyte-specific genes, partially restoring the impaired levels 
of expression in this model of obesity (Fig 6E).
Discussion
Nitrate was considered a non-bioactive metabolite of NO and a potentially toxic dietary 
constituent. However, studies showing that nitrate reduces blood pressure (5; 7; 40) and the 
oxygen demand of exercise (41) indicated that this anion may be beneficial for metabolic 
health. Complementary studies demonstrated that nitrate has anti-obesity and anti-diabetic 
effects, independent of increased mitochondrial biogenesis or PGC1ř expression in liver or 
muscle, in endothelial NOS-deficient mice, a strain prone to a metabolic syndrome-like 
phenotype (6). Similar anti-diabetic effects of nitrate have since been described in Sprague-
Dawley rats (42). Diets low in nitrate and nitrite reduce the concentration of cGMP in 
certain tissues (8). In recent years a role for cGMP signaling in systemic energy balance has 
emerged (32; 43; 44). cGMP was recently demonstrated to induce browning within WAT 
(9). These beige/brite cells (14; 15) have cardiometabolic protective effects in rodents (11; 
16; 18; 19; 22; 23; 45). Thus, we hypothesized that nitrate might contribute to the improved 
metabolic phenotype by inducing the browning response in WAT.
In the present study we demonstrate that nitrate increases the expression of thermogenic 
genes in BAT and activates a brown adipocyte-like transcriptional and functional phenotype 
within WAT. Furthermore, we find that nitrate induces browning of adipocytes through the 
NOS-independent nitrate-nitrite-NO pathway. Thus nitrate activates the thermogenic process 
in a manner distinct from physiological metabolite activators of browning previously 
described (Fig. S9) (20). Our findings suggest a mechanism by which nitrate is reduced to 
NO, which in turn increases cGMP production via soluble guanylyl cyclase activation. 
Increased cGMP concentrations activate PKG, increasing the expression of PGC-1ř and 
other key browning genes such as UCP1 and CIDEA in white adipocytes. Increased 
expression of brown adipocyte-specific and Ś-oxidation pathway genes translates to a brown 
adipocyte-like functional phenotype characterized by increased fatty acid Ś-oxidation (Fig. 
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7). Incidentally, the recently identified mechanism for natriuretic peptide induced browning 
of WAT was also revealed to signal through the cGMP cascade (43), underscoring the 
importance of this signaling pathway for the physiological activation of thermogenesis in 
WAT.
It was observed that the nitrate-induced browning response in WAT was enhanced in 
hypoxia. The nitrate-nitrite-NO pathway is significantly augmented during hypoxia, with 
both the activity and expression of XOR increased in low oxygen conditions (4). The 
pathway has also been implicated in the adaptive response of some tissues to hypoxia (30; 
33; 35). It is conceivable that production of NO from nitrate leads to the enhanced nitrate-
induced browning of WAT observed in hypoxia. The WAT of obese humans, and genetic 
and dietary models of obesity in rodents, is in a hypoxic state (36; 37). Exposure of 
adipocytes to hypoxia leads to cellular metabolic reprogramming, consisting of increased 
glycolysis and fatty acid and TAG synthesis and decreased fatty acid catabolism, that 
contributes to the pathology of obesity (38; 39). The identification of an enhanced capacity 
for nitrate to induce the browning response of WAT in low oxygen conditions through NO, 
which will likely also contribute to improved vascular health in obese individuals where NO 
production is decreased (46), may represent a significant therapeutic opportunity to partly 
reverse this hypoxia mediated pathological state. Indeed, our studies show that the impaired 
expression of several brown adipocyte-specific genes in the WAT of the ob/ob mouse model 
of obesity is partially reversed by nitrate treatment.
From a nutritional perspective, humans are exposed to nitrate as part of their daily diet, with 
green leafy vegetables representing a significant source of the anion. A high vegetable 
component to diets is consistently shown to have a protective role in the development of 
metabolic morbidity (47; 48). It has been suggested that the high nitrate content of 
vegetables is partly responsible for their association with cardiometabolic protection (30; 
34). It is worth speculating that increasing the flux through the nitrate-nitrite-NO pathway 
may be one mechanism through which dietary vegetable consumption confers the associated 
metabolic protection. Given that the concentrations of nitrate utilized in our study are readily 
achievable through dietary vegetable consumption (6; 34), dietary nitrate may also function 
to activate cGMP signaling in human WAT. The possibility that this ubiquitous dietary 
constituent could induce browning of WAT in humans is tantalizing.
It should be noted that the responses of WAT to nitrate were not universally dose-dependent. 
This observation may represent rapid tachyphylaxis and/or resistance to inorganic nitrate, a 
phenomenon well characterized in the clinical use of organic nitrates, in particular at high 
doses. Alternatively, cellular uptake of inorganic nitrate may become rate-limiting or 
saturated at high doses. The NO signaling pathway is also subject to counter regulation 
through a number of disparate mechanisms that include the action of phosphodiesterases 
(PDEs), which may influence the effect of nitrate in WAT (Fig S10). PDEs such as PDE5, 
control cGMP concentrations and therefore inhibit downstream effects such as protein 
kinase G stimulation. Indeed, inhibition of PDE5 is known to stimulate the browning of 
WAT (9).
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In summary, we identify nitrate as a novel non-Ś-adrenergic activator of the browning 
response in WAT and highlight this small anion as both a potential dietary mediator of 
protection from, and potential therapeutic modality for the treatment of, metabolic disease.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. 
Dietary nitrate induces a brown adipocyte-like phenotype in white adipose tissue (WAT) in 
vivo. (A) Increased expression of brown-adipocyte specific genes in subcutaneous WAT of 
nitrate treated rats (Two-way ANOVA, Control vs. 0.35 mM NaNO3 P ≤ 0.01, Control vs. 
0.7 mM NaNO3 P ≤ 0.001, Control vs. 1.4 mM P ≤ 0.0001). (B) Increased concentration of 
brown-adipocyte specific proteins in subcutaneous WAT of nitrate treated rats determined 
by ELISA (Two-way ANOVA, Control vs. 0.35 mM NaNO3 P ≤ 0.001, Control vs. 0.7 mM 
NaNO3 P ≤ 0.05, Control vs. 1.4 mM P ≤ 0.01) (C) Increased concentration of carnitine 
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palmitoyltransferase 1 (CPT1) protein in subcutaneous WAT of nitrate treated rats 
determined by immunoblotting (One-way ANOVA, Control vs. 0.35 mM NaNO3 P ≤ 0.05, 
Control vs. 0.7 mM NaNO3 P ≤ 0.05, Control vs. 1.4 mM NaNO3 P ≤ 0.05). (D) Increased 
citrate synthase activity in subcutaneous WAT of nitrate treated rats (One-way ANOVA, 
Control vs. 0.35 mM NaNO3 P ≤ 0.05, Control vs. 0.7 mM NaNO3 P ≤ 0.05, Control vs. 1.4 
mM P ≤ 0.01) (E) The medium chain fatty acid (MCFA) / long chain fatty acid (LCFA) ratio 
in WAT from nitrate treated rats (One-way ANOVA, Control vs. 0.35 mM NaNO3 P ≤ 0.05, 
Control vs. 0.7 mM NaNO3 P ≤ 0.05, Control vs. 1.4 mM NaNO3 P ≤ 0.01). (F) LC-MS 
analysis of total triacylglycerols (TAGs) from WAT indicates decreased total TAGs stored 
in the WAT of nitrate treated rats (One-way ANOVA, Control vs. 0.35 mM NaNO3 P ≤ 
0.01, Control vs. 0.7 mM NaNO3 P ≤ 0.01). (G) Haematoxylin and eosin staining of inguinal 
WAT of control and nitrate treated rats. Cumulative data from a total of 6 independent 
observations are shown. Data are represented as Mean ± SEM. * P ≤ 0.05, ** P ≤ 0.01, *** 
P ≤ 0.001, **** P ≤ 0.0001.
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Fig. 2. 
Nitrate stimulates expression of brown adipocyte-specific genes and induces an oxidative 
phenotype in primary white adipocytes. (A) The expression of brown adipocyte-specific 
genes in primary white adipocytes treated with nitrate (25 μM NaNO3, 50 μM NaNO3 and 
500 μM NaNO3) (Two-way ANOVA, Control vs. 25 μM NaNO3 P ≤ 0.01, Control vs. 50 
μM NaNO3 P ≤ 0.0001, Control vs. 500 μM NaNO3 P ≤ 0.0001). (B) Basal and stimulated 
(succinate 20 mM) oxygen consumption was increased in white adipocytes treated with 
nitrate, normalized to 106 cells (Two-way ANOVA, Control vs. 50 μM NaNO3 P ≤ 0.01, 
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Control vs. 500 μM NaNO3 P ≤ 0.001). (C) The medium chain fatty acid (MCFA) / long 
chain fatty acid (LCFA) ratio was increased in white adipocytes with nitrate treatment 
(ANOVA, Control vs. 50 μM NaNO3 P ≤ 0.05, Control vs. 500 μM NaNO3 P ≤ 0.05). 
Cumulative data from a total of 4 independent observations are shown. Data are represented 
as Mean ± SEM. * P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001, **** P < 0.0001.
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Fig. 3. 
Fatty acid uptake and Ś-oxidation is increased in nitrate treated primary white adipocytes 
characteristic of the browning response. (A) 13C-enrichment of palmitate (C16:0) was 
significantly increased in nitrate treated adipocytes (One-way ANOVA, P ≤ 0.01). (B) 13C-
enrichment of myristate (C14:0) was significantly increased in nitrate treated adipocytes 
(One-way ANOVA, P ≤ 0.05). (C) 13C-enrichment of laurate (C12:0) was significantly 
increased in nitrate treated adipocytes (One-way ANOVA, P ≤ 0.05). (D) 13C-enrichment of 
citrate was significantly increased in nitrate treated adipocytes (Two-way ANOVA, P ≤ 
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0.0001, Control vs. 50 μM NaNO3 P ≤ 0.0001, Control vs. 500 μM NaNO3 P ≤ 0.001) 
(E) 13C-enrichment of succinate was significantly increased in nitrate treated adipocytes 
(Two-way ANOVA, P ≤ 0.05, Control vs. 500 μM NaNO3 P ≤ 0.05). (F) 13C-enrichment of 
malate was significantly increased in nitrate treated adipocytes (Two-way ANOVA, P ≤ 
0.05, Control vs. 500 μM NaNO3 P ≤ 0.05). Red highlighting indicates increased 
enrichment. Cumulative data from a total of 4 independent observations are shown. Data are 
represented as Mean ± SEM. * P ≤ 0.05, ** P ≤ 0.01,*** P ≤ 0.001, **** P < 0.0001.
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Fig. 4. 
Nitrate functions through the nitrate-nitrite-NO pathway to induce browning of white 
adipocytes. (A) Brown adipocyte-specific gene expression in primary adipocytes treated 
with the NO scavenger PTIO (50 μM) with and without 500 μM NaNO3 (Two-way 
ANOVA, Control vs. 500 μM NaNO3 P ≤ 0.0001, 500 μM NaNO3 vs. 500 μM NaNO3 + 50 
μM PTIO P ≤ 0.0001) (n = 3). (B) Brown adipocyte-specific gene expression in primary 
adipocytes treated with the NOS inhibitor L-NAME (1 mM) with and without 500 μM 
NaNO3 (Two-way ANOVA, Control vs. 500 μM NaNO3 P ≤ 0.001, Control vs. 500 μM 
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NaNO3 + 1 mM L-NAME P ≤ 0.0001) (n = 3). (C) The expression of xanthine 
oxidoreductase (XOR) in primary white adipocytes treated with nitrate (25 μM, 50 μM, 500 
μM) (One-way ANOVA, Control vs. 50 μM NaNO3 P ≤ 0.05, Control vs. 500 μM NaNO3 P 
≤ 0.05) (n = 4). (D) XOR expression in primary adipocytes treated with the NO scavenger 
PTIO (50 μM) with and without 500 μM NaNO3 (One-way ANOVA, Control vs. 500 μM 
NaNO3 P ≤ 0.01, 500 μM NaNO3 vs. 500 μM NaNO3 + 50 μM PTIO P ≤ 0.01) (n = 3). (E) 
XOR expression in primary adipocytes treated with negative control siRNA or siRNA 
against XOR with and without 500 μM NaNO3 (n = 3 / group) (One-way ANOVA, Control 
siRNA vs.Control siRNA + 500 μM NaNO3 P ≤ 0.001, Control siRNA vs XOR siRNA P ≤ 
0.001, Control siRNA vs XOR siRNA+ 500 μM NaNO3 P ≤ 0.001) (F) Brown adipocyte-
specific gene expression in primary adipocytes treated with negative control siRNA or 
siRNA against XOR with and without 500 μM NaNO3 (n = 3 / group) (Two-way ANOVA, 
Control siRNA vs Control siRNA + 500 μM NaNO3 P ≤ 0.0001, Control siRNA + 500 μM 
NaNO3 vs XOR siRNA+ 500 μM NaNO3 P ≤ 0.0001, XOR siRNA vs XOR siRNA+ 500 
μM NaNO3 not significant). Data are represented as Mean ± SEM. * P ≤ 0.05, ** P ≤ 0.01, 
*** P ≤ 0.001, **** P < 0.0001.
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Fig. 5. 
cGMP signaling mediates the nitrate stimulated browning response in white adipocytes. (A) 
LC-MS chromatograms of typical peaks for cGMP from control and 500 μM NaNO3 treated 
primary adipocytes. (B) The concentration of cGMP increases in primary white adipocytes 
treated with nitrate (ANOVA, P ≤ 0.05, Control vs. 50 μM NaNO3 P ≤ 0.05, Control vs. 500 
μM NaNO3 P ≤ 0.05) (n = 4). (C) The concentration of cGMP increases in white adipose 
tissue of rats treated with nitrate (0.35 mM NaNO3, 0.7 mM NaNO3 and 1.4 mM NaNO3) 
(ANOVA, P < 0.05, Control vs. 0.35 mM NaNO3 P ≤ 0.01, Control vs. 0.7 mM NaNO3 P ≤ 
0.05, Control vs. 1.4 mM NaNO3, P = 0.07) (n = 6). (D) Primary adipocytes treated with the 
guanylyl cyclase inhibitor ODQ (1 μM) with and without 500 μM NaNO3 (Two-way 
ANOVA, Control vs. 500 μM NaNO3 P ≤ 0.0001, 500 μM NaNO3 vs. 500 μM NaNO3 + 1 
μM ODQ P ≤ 0.001) (n = 6). (E) Primary adipocytes treated with the protein kinase G 
inhibitor KT5823 (1 μM) with and without 500 μM NaNO3 (Two-way ANOVA, Control vs. 
500 μM NaNO3 P ≤ 0.0001, 500 μM NaNO3 vs. 500 μM NaNO3 + 1 μM KT5823 P ≤ 
0.0001) (n = 3). Data are represented as Mean ± SEM. * P ≤ 0.05, ** P ≤ 0.01, **** P < 
0.0001.
Roberts et al. Page 25
Diabetes. Author manuscript; available in PMC 2015 August 01.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Fig. 6. 
The nitrate stimulated browning response is enhanced in hypoxia. (A) Nitrate (50 μM 
NaNO3) induced expression of xanthine oxidoreductase (XOR) in white adipocytes is 
increased in hypoxia (Two-way ANOVA, Normoxia Control vs. Hypoxia Control P ≤ 0.01, 
Normoxia NaNO3 vs. Hypoxia NaNO3 P ≤ 0.001, Hypoxia Control vs. Hypoxia NaNO3 P ≤ 
0.05) (n = 4). (B) The expression of brown adipocyte-specific genes in primary white 
adipocytes treated with nitrate (50 μM NaNO3) in normoxia or hypoxia and normalized to 
relevant control (normoxia 50 μM nitrate normalized to normoxia control, hypoxia 50 μM 
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nitrate normalized to hypoxia control) (Two-way ANOVA, Normoxia NaNO3 vs. Hypoxia 
NaNO3 P ≤ 0.001) (n = 4). (C) The expression of XOR in white adipose tissue (WAT) of 
nitrate treated (0.7 mM NaNO3) rats is increased in hypoxia (Two-way ANOVA, Normoxia 
Control vs. Hypoxia Control P ≤ 0.01, Normoxia NaNO3 vs. Hypoxia NaNO3 P ≤ 0.01, 
Hypoxia Control vs. Hypoxia NaNO3 P ≤ 0.05) (n = 5). (D) The increased expression of 
brown-adipocyte specific genes in WAT of nitrate treated rats is enhanced during hypoxia 
(Two-way ANOVA, Normoxia 0.7 mM NaNO3 vs. Hypoxia 0.7mM NaNO3, P < 0.0001) (n 
= 5). (E) The reduced expression of brown adipocyte-specific genes in WAT of the ob/ob 
mouse compared to wild type controls is partially restored following nitrate treatment. 
(Two-way ANOVA, Wild Type Control vs. ob/ob Control P ≤ 0.0001, Wild Type Control 
vs. Wild Type NaNO3 P ≤ 0.01, ob/ob Control vs. ob/ob NaNO3 P ≤ 0.0001) Data are 
represented as Mean ± SEM. * P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001, **** P < 0.0001.
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Fig. 7. 
Proposed mechanism for nitrate-induced browning of white adipocytes. After entering the 
cell, nitrate is reduced first to nitrite, then to nitric oxide (NO). NO increases cGMP 
production via soluble guanylyl cyclase activation. Increased cGMP concentrations activate 
PKG, increasing the expression of PGC-1ř and key browning genes. Increased expression 
of brown adipocyte-specific and Ś-oxidation pathway genes confers an oxidative brown 
adipocyte-like functional phenotype on the white adipocytes. ACAD, acyl-CoA 
dehydrogenase; CIDEA, cell death-inducing DFFA-like effector a; cGMP, cyclic guanosine 
monophosphate; CPT1, carnitine palmitoyltransferase; CYCS, cytochrome c; GTP, 
Guanosine triphosphate; LCFA, long chain fatty acid; NO, nitric oxide; ODQ, 1H-[1,2, 
4]oxadiazolo[4,3-a]quinoxalin-1-one; PGC1ř, peroxisome proliferator-activated receptor 
gamma coactivator 1-alpha; SCFA, short chain fatty acid; UCP1, uncoupling protein 1; 
XOR, xanthine oxidoreductase.
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